ANZBMS 2026 , ,
Presentations this author is a contributor to:
Rethinking long‑term denosumab therapy: extending treatment intervals in low‑risk patients (#11)
12:15 PM
Brenda Ta
Roger Melick Young Investigator Award Symposium